Hepatitis B Virus X Protein Affects miR-16 Family in Liver Cancer Cells
Author Information
Author(s): Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E
Primary Institution: Sun-Yat-Sen University
Hypothesis
HBx expression in hepatocytes would alter host cellular miRNA expression, leading to HCC initiation and progression.
Conclusion
HBx alters the expression of miRNAs in malignant hepatocytes, particularly downregulating the miR-16 family, which may serve as a therapeutic target for HBV-associated HCC.
Supporting Evidence
- HBx caused widespread suppressions of miRNA expression, including the miR-16 family, in HepG2 cells.
- Downregulation of the miR-16 family was validated by qRT-PCR analysis of HepG2, Huh7, and SK-HEP-1 cells.
- CCND1, a target of the miR-16 family, was derepressed in HBx-expressing HepG2 cells.
Takeaway
The study found that a protein from the hepatitis B virus can change how certain tiny molecules in liver cells work, which might help cancer grow. Targeting these molecules could help treat liver cancer.
Methodology
miRNA microarray and quantitative reverse-transcription polymerase chain reactions (qRT-PCRs) were performed to identify miRNAs that were differentially regulated by HBx in HCC cells.
Limitations
The study primarily used in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website